Taking into account the clinical background of the analyzed material, we concluded that, based on serum GDF15, EGF, and neopterin concentrations, the groups of children with CKD stages 1–3 could be differentiated from patients with CKD stages 4–5. This evidence concerns the gene EGF and chronic kidney disease.